scholarly journals Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions

2015 ◽  
Vol 29 (1) ◽  
pp. 25-33 ◽  
Author(s):  
Thaer Khoury ◽  
Prasanna R Kumar ◽  
Zaibo Li ◽  
Rouzan G Karabakhtsian ◽  
Souzan Sanati ◽  
...  
2021 ◽  
Vol 216 (3) ◽  
pp. 622-632
Author(s):  
Aya Y. Michaels ◽  
Paula S. Ginter ◽  
Katerina Dodelzon ◽  
Matthew R. Naunheim ◽  
Genevieve N. Abbey

2004 ◽  
Vol 182 (4) ◽  
pp. 1075-1080 ◽  
Author(s):  
Xiaoming Chen ◽  
Constance D. Lehman ◽  
Katherine E. Dee

2017 ◽  
Vol 68 (4) ◽  
pp. 401-408 ◽  
Author(s):  
Romuald Ferré ◽  
Shaza AlSharif ◽  
Ann Aldis ◽  
Benoît Mesurolle

Purpose The study sought to investigate the outcome of breast magnetic resonance–guided biopsies as a function of the indication for magnetic resonance imaging (MRI), the MRI features of the lesions, and the performance or not of a targeted second-look ultrasound (SLUS) prior breast MRI-guided biopsy. Methods We identified 158 women with MRI-detected breast lesions scheduled for MRI-guided biopsy (2007-2013). Patient demographics, performance of targeted SLUS, imaging characteristics, and subsequent pathology results were reviewed. Results Three biopsies were deferred, and 155 lesions were biopsied under MRI guidance (155 women; median age 55.14 years; range 27-80 years). Ninety-eight women underwent a SLUS prior to the MRI-guided biopsy (63%). Of the 155 biopsied lesions, 23 (15%) were malignant, 106 (68%) were benign, and 26 (17%) were high risk. Four of 15 surgically excised high-risk lesions were upgraded to malignancy (27%). Most of the biopsied lesions corresponded to non–mass-like enhancement (81%, 126 of 155) and most of the biopsies (52%, 81 of 155) were performed in a screening context. No demographic or MRI features were associated with malignancy. No differences were noted between the 2 subgroups (prior SLUS vs no prior SLUS) except for the presence of a synchronous carcinoma associated with a likelihood of targeted SLUS before MRI-guided biopsy ( P = .001). Conclusion A negative SLUS does not influence the pathology outcome of a suspicious lesion biopsied under MR guidance.


2012 ◽  
Vol 23 (5) ◽  
pp. 1415-1419 ◽  
Author(s):  
Siegfried A. Schwab ◽  
Michael A. Kuefner ◽  
Boris Adamietz ◽  
Karl Engelhard ◽  
Bastian Keck ◽  
...  

2020 ◽  
Vol 184 (3) ◽  
pp. 881-890
Author(s):  
Yoav Amitai ◽  
Tehillah S. Menes ◽  
Anabel Scaranelo ◽  
Rachel Fleming ◽  
Supriya Kulkarni ◽  
...  

Breast Cancer ◽  
2019 ◽  
Vol 27 (3) ◽  
pp. 405-414
Author(s):  
Satoko Okamoto ◽  
Shu-Tian Chen ◽  
James D. Covelli ◽  
Wendy B. DeMartini ◽  
Bruce L. Daniel ◽  
...  

2013 ◽  
Vol 26 (6) ◽  
pp. 762-771 ◽  
Author(s):  
Shweta Chaudhary ◽  
Loretta Lawrence ◽  
Geraldine McGinty ◽  
Karen Kostroff ◽  
Tawfiqul Bhuiya

2007 ◽  
Vol 13 (1) ◽  
pp. 55-61 ◽  
Author(s):  
Lisa E. Esserman ◽  
Ladan Lamea ◽  
Silvio Tanev ◽  
Robert Poppiti

Sign in / Sign up

Export Citation Format

Share Document